Assessment of paroxetine-induced sexual dysfunction using the Changes in Sexual Functioning Questionnaire

Area of Science:

• Psychopharmacology
• Sexual Medicine
• Clinical Psychology

Background:

• Illness and medications can significantly alter sexual functioning.
• A validated instrument is needed to measure these changes.
• Paroxetine treatment for major depression is associated with sexual side effects.

Purpose of the Study:

• To introduce the Changes in Sexual Functioning Questionnaire (CSFQ).
• To assess the CSFQ's utility in a pilot study of patients with major depression.
• To categorize sexual functioning changes during paroxetine treatment.

Main Methods:

• Development of the Changes in Sexual Functioning Questionnaire (CSFQ).
• Pilot study involving patients with major depression treated with paroxetine.
• Analysis of CSFQ change scores to differentiate patient groups and sexual response factors.

Main Results:

• The CSFQ successfully delineated three patient groups: increased libido without dysfunction, anorgasmia with potential spontaneous resolution, and long-term sexual dysfunction.
• Change scores differentiated global sexual function, specific response factors, and drug-specific side effects.
• All patients achieved therapeutic response, with sexual experiences fitting into one of the three identified categories.

Conclusions:

• The Changes in Sexual Functioning Questionnaire is a valuable tool for assessing sexual function changes in clinical and research settings.
• The CSFQ aids in understanding the spectrum of sexual side effects associated with paroxetine treatment.
• The instrument facilitates the categorization of sexual functioning outcomes in patients undergoing pharmacotherapy.